SEATTLE, April 16, 2018 /PRNewswire/ -- RareCyte, Inc., a global rare cell detection and liquid biopsy company, announcesits newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chicago April 15 through 18. CyteFinder HT, RareCyte's newest
About RareCyte, Inc. RareCyte offers next-generation tools and reagents for applications enabled by the analysis and capture of rare cells from tissue and blood including next generation liquid biopsy. The company has a long pedigree in developing advanced precision life science systems used in cutting-edge labs worldwide. Our customers perform innovative research at prestigious academic institutions, bring new therapeutics to market, and perform a wide-range of single cell applications in oncology, prenatal testing and infectious disease. For more information about RareCyte, visit www.rarecyte.com.
View original content:http://www.prnewswire.com/news-releases/rarecyte-introduces-the-cytefinder-ht-instrument-at-aacr-for-high-throughput-slide-based-imaging-optimized-for-single-cell-liquid-biopsy-300630242.html
SOURCE RareCyte, Inc.
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All